1
TITLE: Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)
AUTHORS: Anne Catherine Pouleur; Stefan Anker; Dulce Brito; Oana Brosteanu; Dirk Hasenclever; Barbara Casadei; Frank Edelmann; Gerasimos Filippatos; Damien Gruson; Ignatios Ikonomidis; Renaud Lhommel; Masliza Mahmod; Stefan Neubauer; Alexandre Persu; Bernhard L Gerber; Stefan Piechnik; Burkert Pieske; Elisabeth Pieske Kraigher; Fausto Pinto; Piotr Ponikowski; Michele Senni; Jean Noel Trochu; Nancy Van Overstraeten; Rolf Wachter; Jean Luc Balligand; ...More
PUBLISHED: 2018, SOURCE: ESC HEART FAILURE, VOLUME: 5, ISSUE: 5
INDEXED IN: Scopus WOS